Latest News

  • Alkermes Plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2019 and Provides Financial Expectations for 2020 Read More
  • Alkermes to Host Conference Call to Discuss Fourth Quarter and Year-End 2019 Financial Results Read More
  • Alkermes Announces U.S. Food and Drug Administration Acceptance of ALKS 3831 New Drug Application for Treatment of Schizophrenia and Bipolar I Disorder Read More

Investors

Working at Alkermes